Michael H. Tomasson
- Hematology top 0.5%
- Molecular Biology top 5%
- Oncology top 2%
- Genetics top 1%
- Immunology top 5%
- Co-authors
- Ravi VijJennifer CainD. Gary GillilandJulie O’NealMartin CarrollIfor R. WilliamsRichard A. Van EttenTodd R. Golub
- Topics
- Multiple Myeloma Research and Treatments (66 papers)Protein Degradation and Inhibitors (24 papers)Acute Myeloid Leukemia Research (14 papers)
- Cited by
- HematologyGeneticsOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Medicine
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Michael H. Tomasson
109 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 110
- Hematology 1.8k
- Molecular Biology 1.6k
- Oncology 1.3k
- Genetics 659
- Immunology 486
Countries citing papers authored by Michael H. Tomasson
This map shows the geographic impact of Michael H. Tomasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael H. Tomasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael H. Tomasson more than expected).
Fields of papers citing papers by Michael H. Tomasson
This network shows the impact of papers produced by Michael H. Tomasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael H. Tomasson. The network helps show where Michael H. Tomasson may publish in the future.
Co-authorship network of co-authors of Michael H. Tomasson
This figure shows the co-authorship network connecting the top 25 collaborators of Michael H. Tomasson. A scholar is included among the top collaborators of Michael H. Tomasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael H. Tomasson. Michael H. Tomasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 76 | |
| 3 | 3 | |
| 4 | 15 | |
| 5 | 8 | |
| 6 | NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma | 1 |
| 7 | 20 | |
| 8 | 45 | |
| 9 | 25 | |
| 10 | 8 | |
| 11 | 281 | |
| 12 | 32 | |
| 13 | 34 | |
| 14 | 110 | |
| 15 | 75 | |
| 16 | Legal, ethical, and conceptual bottlenecks to the development of useful genomic tests. | 6 |
| 17 | 28 | |
| 18 | 19 | |
| 19 | 18 | |
| 20 | 213 |
About Michael H. Tomasson
Michael H. Tomasson is a scholar working on Hematology, Oncology and Genetics, having authored 116 papers that have together received 3.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (66 papers), Protein Degradation and Inhibitors (24 papers) and Acute Myeloid Leukemia Research (14 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (659 citations) and Oncology (1.3k citations). Michael H. Tomasson has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Ravi Vij, Jennifer Cain, D. Gary Gilliland, Julie O’Neal, Martin Carroll, Ifor R. Williams, D. Gary Gilliland, Richard A. Van Etten, Todd R. Golub and George F. Barker. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.